These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

905 related articles for article (PubMed ID: 1085745)

  • 61. Enzyme polymorphism in the classification of human malignant lymphoma.
    Radzun HJ; Schmidt D; Parwaresch MR
    J Cancer Res Clin Oncol; 1981; 101(1):53-7. PubMed ID: 6974172
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers.
    Delia D; Bonati A; Giardini R; Villa S; De Braud F; Cattoretti G; Rilke F
    Hematol Oncol; 1986; 4(3):237-48. PubMed ID: 3095211
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Expression of a T-cell antigen (Leu-1) by B-cell lymphomas.
    Burns BF; Warnke RA; Doggett RS; Rouse RV
    Am J Pathol; 1983 Nov; 113(2):165-71. PubMed ID: 6605688
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Benign and malignant lymphoid lesions of the stomach. A histological reappraisal in the light of the Kiel classification for non-Hodgkin's lymphomas.
    Vanden Heule B; Van Kerkem C; Heimann R
    Histopathology; 1979 Jul; 3(4):309-20. PubMed ID: 468132
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunologic aspects and pathology of the malignant lymphomas.
    Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
    Cancer; 1978 Aug; 42(2 Suppl):911-21. PubMed ID: 356957
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunologic phenotypes of diffuse, aggressive, non-Hodgkin's lymphomas. Correlation with clinical features.
    Cossman J; Jaffe ES; Fisher RI
    Cancer; 1984 Oct; 54(7):1310-7. PubMed ID: 6380700
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prognostic value of the Kiel classification of malignant non-Hodgkin's lymphomas.
    Bettini R; Chelazzi G
    Tumori; 1979 Apr; 65(2):207-13. PubMed ID: 462572
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Surface marker studies in chronic lymphocytic leukaemia and non-Hodgkin's lymphoma.
    Leong AS; Forbes IJ; Cowled PA; Sage RE; Black RB; Dale B; Zalewski PD
    Pathology; 1979 Jul; 11(3):461-71. PubMed ID: 392424
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Germinal center cell-derived lymphomas of the skin.
    Kerl H; Kresbach H
    J Dermatol Surg Oncol; 1984 Apr; 10(4):291-5. PubMed ID: 6608541
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immune marker expression in 53 lymphomas of high-grade malignancy.
    Pallesen G; Madsen M; Schifter S
    Histopathology; 1983 Nov; 7(6):841-57. PubMed ID: 6689315
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumor.
    Bernard A; Murphy SB; Melvin S; Bowman WP; Caillaud J; Lemerle J; Boumsell L
    Blood; 1982 Mar; 59(3):549-54. PubMed ID: 6977384
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Malignant lymphomas as tumours of the immune system.
    Berard CW; Cossman J; Jaffe ES
    Br J Cancer; 1980 Jul; 42(1):1-20. PubMed ID: 7000112
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunohistologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies. Follicular and diffuse lymphomas of small-cleaved-cell type are related but distinct entities.
    Harris NL; Nadler LM; Bhan AK
    Am J Pathol; 1984 Nov; 117(2):262-72. PubMed ID: 6437232
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunoelectron microscopic localization of immunoglobulin in B-cell lymphomas.
    Mimura R; Hansmann ML; Lennert K
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(3):207-20. PubMed ID: 2879378
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Histomorphology and cytomorphology of cutaneous B-cell lymphomas.
    Kerl H; Burg G
    J Dermatol Surg Oncol; 1984 Apr; 10(4):266-70. PubMed ID: 6608538
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A novel human T cell antigen preferentially expressed on mature T cells and shared by both well and poorly differentiated B cell leukemias and lymphomas.
    Kamoun M; Kadin ME; Martin PJ; Nettleton J; Hansen JA
    J Immunol; 1981 Sep; 127(3):987-91. PubMed ID: 6790625
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Histological and immunohistological analysis of human lymphomas.
    Falini B; Pileri S; Martelli MF
    Crit Rev Oncol Hematol; 1989; 9(4):351-419. PubMed ID: 2688682
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Malignant lymphomas involving the central nervous system--a morphological and immunohistochemical study of 32 cases.
    Simon J; Jones EL; Trumper MM; Salmon MV
    Histopathology; 1987 Apr; 11(4):335-49. PubMed ID: 3596473
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Primary malignant lymphomas of the central nervous system: a histological and immunohistological study of 12 cases.
    Allegranza A; Mariani C; Giardini R; Brambilla MC; Boeri R
    Histopathology; 1984 Sep; 8(5):781-91. PubMed ID: 6549172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.